MicroRNA‑3653 Inhibits the Growth and Metastasis of Hepatocellular Carcinoma by Inhibiting ITGB1

Overview

Journal Oncol Rep

Specialty Oncology

Date 2019 Jan 22

PMID 30664185

Citations 13

Authors

Lijuan Zhang

Tao Zhang

Zerun Deng

Lihua Sun

Affiliations

Soon will be listed here.

Abstract

microRNAs (miRNAs) play critical roles in hepatocellular carcinoma (HCC). However, the expression and biological function of miR‑3653 in HCC remain unknown. The present study demonstrated that miR‑3653 expression was significantly decreased in HCC tissues and cells using qRT‑PCR. A decreased miR‑3653 level was associated with unfavorable clinical features and poor prognosis of HCC patients. MTT, BrdU, Transwell and western blot assays showed that miR‑3653 overexpression inhibited the growth, migration, invasion and epithelial‑mesenchymal transition (EMT) of HCCLM3 cells while its knockdown promoted the growth and metastatic ability of Hep3B cells. In vivo experiments showed that miR‑3653 overexpression inhibited the subcutaneous and the lung metastasis of HCCLM3 cells in nude mice. Mechanistically, integrin‑β1 (ITGB1) was identified to be the downstream target of miR‑3653 in HCC. ITGB1 overexpression reversed the inhibitory effects of miR‑3653 on the growth, metastasis and EMT of HCCLM3 cells.

Citing Articles

miR-3653-3p Expression in PBMCs: Unveiling the Diagnostic Potential for Ovarian Cancer.

Delek F, Tuncer S, Odemis D, Erciyas S, Sukruoglu Erdogan O, Saip P Biochem Genet. 2024; .

PMID: 38705961 DOI: 10.1007/s10528-024-10819-0.

Comprehensive analysis of differentially expressed miRNAs in hepatocellular carcinoma: Prognostic, predictive significance and pathway insights.

Smith K, Beach D, Silva R, Balazs G, Salani F, Crea F PLoS One. 2024; 19(4):e0296198.

PMID: 38635644 PMC: 11025735. DOI: 10.1371/journal.pone.0296198.

RUNX1/miR-429 feedback loop promotes growth, metastasis, and epithelial-mesenchymal transition in oral squamous cell carcinoma by targeting ITGB1.

Lu X, Yang Y, Chen J, Zhao T, Zhao X Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(7):5289-5302.

PMID: 38277041 DOI: 10.1007/s00210-024-02960-9.

MiR-3653 blocks autophagy to inhibit epithelial-mesenchymal transition in breast cancer cells by targeting the autophagy-regulatory genes ATG12 and AMBRA1.

Song H, Zhao Z, Ma L, Zhang B, Song Y Chin Med J (Engl). 2023; 136(17):2086-2100.

PMID: 37464439 PMC: 10476840. DOI: 10.1097/CM9.0000000000002569.

Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma.

Niu Z, Wang W, Niu X World J Gastroenterol. 2022; 28(46):6433-6477.

PMID: 36569275 PMC: 9782839. DOI: 10.3748/wjg.v28.i46.6433.

References

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

El-Serag H, Rudolph K . Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132(7):2557-76. DOI: 10.1053/j.gastro.2007.04.061. View

Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob S, Patel T . MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007; 133(2):647-58. PMC: 4285346. DOI: 10.1053/j.gastro.2007.05.022. View

Nelson K, Weiss G . MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther. 2008; 7(12):3655-60. DOI: 10.1158/1535-7163.MCT-08-0586. View

Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce C . MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med. 2009; 12(6A):2189-204. PMC: 4514099. DOI: 10.1111/j.1582-4934.2008.00533.x. View

Yilmaz M, Christofori G . EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009; 28(1-2):15-33. DOI: 10.1007/s10555-008-9169-0. View

Furuta M, Kozaki K, Tanaka S, Arii S, Imoto I, Inazawa J . miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2009; 31(5):766-76. DOI: 10.1093/carcin/bgp250. View

Hunt S, Jones A, Hinsley E, Whawell S, Lambert D . MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Lett. 2010; 585(1):187-92. DOI: 10.1016/j.febslet.2010.11.038. View

Zheng F, Liao Y, Cai M, Liu Y, Liu T, Chen S . The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut. 2011; 61(2):278-89. DOI: 10.1136/gut.2011.239145. View

10.

Braconi C, Henry J, Kogure T, Schmittgen T, Patel T . The role of microRNAs in human liver cancers. Semin Oncol. 2011; 38(6):752-63. PMC: 3928803. DOI: 10.1053/j.seminoncol.2011.08.001. View

11.

Zhu X, Dong Q, Zhang X, Deng B, Jia H, Ye Q . microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. Int J Mol Med. 2012; 30(6):1321-6. DOI: 10.3892/ijmm.2012.1140. View

12.

Maluccio M, Covey A . Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012; 62(6):394-9. DOI: 10.3322/caac.21161. View

13.

Yates L, Norbury C, Gilbert R . The long and short of microRNA. Cell. 2013; 153(3):516-9. DOI: 10.1016/j.cell.2013.04.003. View

14.

Greenhill C . Hepatocellular carcinoma: New insight into angiogenesis in hepatocellular carcinoma: involvement of microRNA-26a. Nat Rev Gastroenterol Hepatol. 2013; 11(1):3. DOI: 10.1038/nrgastro.2013.236. View

15.

Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q . MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. Oncotarget. 2015; 6(15):13216-28. PMC: 4537009. DOI: 10.18632/oncotarget.3916. View

16.

Wu X, Li S, Xu X, Wu S, Chen R, Jiang Q . The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer. Int J Clin Exp Pathol. 2015; 8(3):2840-51. PMC: 4440102. View

17.

Hu C, Ni Z, Li B, Yong X, Yang X, Zhang J . hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation. Gut. 2015; 66(1):31-42. DOI: 10.1136/gutjnl-2015-309322. View

18.

Kurozumi A, Goto Y, Matsushita R, Fukumoto I, Kato M, Nishikawa R . Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer. Cancer Sci. 2015; 107(1):84-94. PMC: 4724812. DOI: 10.1111/cas.12842. View

19.

Yang J, Hou Y, Zhou M, Wen S, Zhou J, Xu L . Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network. Int J Biochem Cell Biol. 2015; 71:62-71. DOI: 10.1016/j.biocel.2015.12.004. View

20.

He B, Xiao Y, Tang B, Wu Y, Hu C, Xie R . hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a. Sci Rep. 2016; 6:21955. PMC: 4763288. DOI: 10.1038/srep21955. View